Anti-infective antibodies--reviving an old paradigm

Area of Science:

• Immunology
• Infectious Diseases
• Biotechnology

Background:

• Antibody therapy has a long history in treating infections.
• Advances in monoclonal antibody technology have renewed interest in this therapeutic approach.
• Novel methods for producing antibodies are emerging.

Purpose of the Study:

• To review the current landscape of antibody therapy for infections.
• To specifically examine the potential of antibodies in combating pandemic influenza.
• To assess the feasibility of using food-derived antibodies as a prophylactic against diarrhoeal diseases.

Main Methods:

• Literature review focusing on antibody therapy, pandemic flu, and novel delivery methods.
• Analysis of existing research on monoclonal antibodies and their applications.
• Exploration of transgenic chicken egg technology for antibody production.

Main Results:

• Antibody therapy, particularly using monoclonal antibodies, shows significant promise for treating various infections.
• The potential role of antibodies in mitigating pandemic flu outbreaks is a key area of investigation.
• Antibodies derived from transgenic chicken eggs present a novel strategy for oral prophylaxis against diarrhoeal diseases.

Conclusions:

• Monoclonal antibody technology is revitalizing antibody-based treatments for infectious diseases.
• Further research is warranted to explore antibodies for pandemic flu preparedness.
• Food-derived antibodies from transgenic sources offer a promising avenue for preventing diarrhoeal diseases.